Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes.
Hagberg CE; Mehlem A; Falkevall A; Muhl L; Fam BC; Ortsäter H; Scotney P; Nyqvist D; Samén E; Lu L; Stone-Elander S; Proietto J; Andrikopoulos S; Sjöholm A; Nash A; Eriksson U; Nature, 2012, vol. 490, issue 7420, p 426, ISSN 14764687. ISBN 14764687.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef